368 filings
Page 3 of 19
EFFECT
50m xwphoutz7i6s4lrz
1 Nov 23
Notice of effectiveness
12:15am
CORRESP
sj1pvfj
30 Oct 23
Correspondence with SEC
12:00am
CORRESP
f9dw6ux 3b0
30 Oct 23
Correspondence with SEC
12:00am
CORRESP
j49 is2t5l0yg7qr
27 Oct 23
Correspondence with SEC
12:00am
CORRESP
8olx7zqi6a4xtyr3ul1
27 Oct 23
Correspondence with SEC
12:00am
CORRESP
76eb140vq 7vp1
24 Oct 23
Correspondence with SEC
12:00am
CORRESP
e17tdk
24 Oct 23
Correspondence with SEC
12:00am
FWP
9c45b7sufsb9 rgj31
5 Oct 23
Free writing prospectus
5:05pm
FWP
3beqmd07uff
3 Oct 23
Free writing prospectus
5:47pm
8-K
qqfyobk
28 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:25pm
8-K
db9wmdcq
27 Sep 23
Other Events
4:03pm
UPLOAD
yks1n
21 Sep 23
Letter from SEC
12:00am
SC 13D/A
6wslww7g4icmjd
18 Sep 23
AVENUE THERAPEUTICS / Fortress Biotech ownership change
5:08pm
4
oq51xeuw1vqxz5e ahf
12 Sep 23
AVENUE THERAPEUTICS / LINDSAY A MD ROSENWALD ownership change
9:03am
4
24ctfdi
12 Sep 23
Change in insider ownership
9:02am
8-K
cxvz7a5yfnk
8 Sep 23
Entry into a Material Definitive Agreement
4:15pm